Tirzepatide acts directly on appetite signalling by activating GLP-1 and GIP receptors, increasing satiety, slowing gastric emptying and enhancing insulin secretion
This mechanism suggests the peptide can restore youthful patterns of gene expression in senescent cells
Medications like Semaglutide and Tirzepatide work by mimicking this hormones action, slowing down digestion to help you feel full longer and controlling blood sugar spikes that can fuel cravings
A patient paying $120/month for 6 months generates $720 in revenue
Semaglutide comparisons with Naltrexone/Bupropion revealed significant associations with lower cataracts (HR 0.37, 95% CI: 0.180.75, p = 0.004), oculomotor binocular dysfunction (HR 0.46, 95% CI: 0.270.79, p = 0.004), dry eye disease (HR 0.36, 95% CI: 0.180.73, p = 0.003), and ametropic accommodative dysfunction (HR 0.50, 95% CI: 0.290.87, p = 0.012)
besides this, shortages and supply chain difficulties by pharma companies with constrained production capacity and a risk of counterfeit products in the market